Results 1 to 10 of about 348,537 (304)

30-Year Development of Inactivated Virus Vaccine in China

open access: yesPharmaceutics, 2023
Inactivated vaccines are vaccines made from inactivated pathogens, typically achieved by using chemical or physical methods to destroy the virus’s ability to replicate.
Yao Cheng, Xiaoming Yang, Jinrong Shi
exaly   +3 more sources

Analysing transcriptomic signatures and identifying potential genes for the protective effect of inactivated COVID-19 vaccines [PDF]

open access: yesPeerJ, 2023
Inactivated vaccines are one of the most effective strategies for controlling the coronavirus disease 2019 (COVID-19) pandemic. However, the response genes for the protective effect of inactivated vaccines are still unclear.
Hongquan Chen   +5 more
doaj   +3 more sources

Effect of Homologous or Heterologous Vaccine Booster Over Two Initial Doses of Inactivated COVID-19 Vaccine

open access: yesExpert Review of Vaccines
Introduction Inactivated vaccines were delivered to low- and middle-income countries during the early pandemics of COVID-19. Currently, more than 10 inactivated COVID-19 vaccines have been developed. Most inactivated vaccines contain an inactivated whole-
Punnee Pitisuttithum
exaly   +3 more sources

Quality control procedure for Coccidial vaccines versus different routes of immunization [PDF]

open access: yesVeterinary World, 2022
Background and Aim: Coccidiosis is an enteric infection caused by a protozoon (Eimeria tenella). Coccidiosis is known to have a negative impact on the economy. Coccidiosis is controlled using anticoccidial drugs, antibiotics, and vaccines.
Arwa Elnaggar, Hala Mahmoud, Sahar Saber
doaj   +1 more source

Evaluation of formaldehyde and binary ethylenimine inactivated Newcastle Disease Virus Vaccine from new isolate compared with imported NDV vaccine [PDF]

open access: yesBenha Veterinary Medical Journal, 2020
Even massive vaccination programs, the incidence of Newcastle Disease virus (NDV) outbreaks in Egypt is still frequent with appearing new isolates that need production of new vaccines. In this study, NDV vaccine was prepared by using a new local isolate (
sausan El-Mahdy   +3 more
doaj   +1 more source

A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations

open access: yesVaccines, 2023
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and vaccination is critical for preventing further spread or resurgence of the outbreak ...
Lidan Hu   +8 more
doaj   +1 more source

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine

open access: yesEmerging Microbes and Infections, 2021
Since the outbreak of COVID-19, a variety of vaccine platforms have been developed. Amongst these, inactivated vaccines have been authorized for emergency use or conditional marketing in many countries.
Jialu Zhang   +18 more
doaj   +1 more source

Inactivated smallpox vaccine. A comparison of inactivation methods [PDF]

open access: yesJournal of Hygiene, 1970
Vaccines were prepared from a single pool of high-titred vaccinia virus and inactivated by six methods, namely heat, formalin, hydroxylamine, β-propiolactone, ultraviolet irradiation, and visible light and methylene blue. Large doses of the vaccines were required to protect mice against intracerebral challenge.
G S, Turner, E J, Squires, H G, Murray
openaire   +2 more sources

EVALUATION OF RECOMBINANT AVIAN INFLUENZA COMPARED TO INACTIVATED VACCINES TO INDUCE IMMUNE RESPONSE IN CHICKEN [PDF]

open access: yesArab Universities Journal of Agricultural Sciences, 2018
The present Avian Influenza epidemic in Egypt is consider one of the major problems facing the poultry field and caused by circulation of genetically and antigenetically diverse influenza H5N1 viruses.
Dalia Omar, K. El-Dougdoug, B. Othman
doaj   +1 more source

Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines

open access: yesExpert Review of Vaccines, 2023
Introduction Approximately half of the 13.4 billion COVID-19 vaccine doses administered globally were inactivated or viral vector platforms. The harmonization and optimization of vaccine regimens has become a key focus of policymakers and health-care ...
Anthony M. Marchese   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy